Ignite International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (“IGNITE” or the “Company”) is pleased to announce today the appointment of Mr. Thomas Kofman, an independent, non-executive director, to its board of directors.

Mr. Kofman has over thirty-five years of experience in capital markets on both the debt and equity side, working both as agent and principal. Mr. Kofman has served in a number of senior management positions with a variety of companies, including his role as a founding officer of the first real estate investment trust (“REIT”) in Canada. Mr. Kofman also founded and served as Chairman of M Partners Inc., a full-service institutional investment bank. During his tenure at M Partners Inc., Mr. Kofman oversaw over $6 billion dollars of global transactions within numerous industry verticals, including establishing one of the first publicly traded companies in the Canadian medical marijuana space.


Mr. Kofman is a Chartered Professional Accountant and currently serves as a director of three companies in various industries. Mr. Kofman works closely with Erase Cancer, a charity founded by his family, and in the past six years has raised over $500,000 for Camp Ooch; a camp for children suffering from cancer.

“IGNITE is very pleased to have someone of Mr. Kofman’s character and caliber join our board. Over and above his extensive experience in both the capital markets and the cannabis space, Mr. Kofman truly understands IGNITE’s brand strategy and shares the management team’s vision and enthusiasm about what the IGNITE brand can achieve globally,” said President, Curtis Heffernan.

In conjunction with his appointment, Mr. Kofman will be granted 100,000 stock options, vesting over three (3) years from the date of grant, to purchase subordinate voting shares of IGNITE at an exercise price of $2.25 per share.

In concert with Mr. Kofman’s appointment, Mr. Scott Rohleder announced his retirement from IGNITE’s board of directors. The entire IGNITE team wishes to thank Mr. Rohleder for his incredibly valuable contribution during his tenure and wish him the best of luck in his future endeavors.

ABOUT IGNITE

IGNITE is a CSE-listed and OTCQX traded company operating in permissible CBD and cannabis sectors in addition to other product categories. IGNITE intends to expand its business, which currently includes branding, marketing, licensing, sales and distribution, across the United States, Canada, the United Kingdom and Mexico by leveraging multiple product platforms. The Company intends to affect this expansion through brand leverage, product development, targeted marketing and strategic supply chain partnerships in each of its active and target jurisdictions.

For further information, please contact:
IGNITE Investor Relations
Tel: 905-669-0212
Email: ir@ignite.co

Click here to connect with Ignite International Brands (CSE:BILZ) for an Investor Presentation

SOURCE

Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Bart Oates Esq., President of the NFL Alumni Association, to its Advisory Board.

Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/

Keep reading... Show less